Curiox Biosystems Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-9,049	-8,089	-10,040	-11,495	-14,524	-6,279
Depreciation & Amortization	2,617	2,578	1,952	1,598	1,236	1,120
Loss (Gain) From Sale of Assets	123.18	123.27	-13.02	12.11	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	84.1	-
Stock-Based Compensation	837.84	777.17	-8.84	678.35	613.76	167.82
Provision & Write-off of Bad Debts	0.02	2.14	17.29	1.88	12.66	27.41
Other Operating Activities	-4,483	-5,163	-334.89	301.64	7,214	3,307
Change in Accounts Receivable	1,892	2,737	227.68	1,212	75.22	-2,227
Change in Inventory	-502.37	-458.81	195.89	-829.5	-1,163	137.56
Change in Accounts Payable	-1,193	-1,196	-688.69	-1,509	809.8	1,192
Change in Other Net Operating Assets	-753.08	-1,009	528.91	140.75	516.07	-106.52
Operating Cash Flow	-10,511	-9,698	-8,164	-9,888	-5,126	-2,661
Capital Expenditures	-228.96	-257.88	-211.53	-822.86	-261.26	-188.39
Sale of Property, Plant & Equipment	-	-	1.79	-	-	58.68
Sale (Purchase) of Intangibles	-	-	-	-17.9	-	-
Investment in Securities	-9,000	-4,000	3,125	5,691	-8,007	2,260
Other Investing Activities	-17.86	-16.81	-16.69	-116.92	-43.25	-26.19
Investing Cash Flow	-9,247	-4,275	2,898	4,734	-8,311	2,105
Long-Term Debt Issued	-	19,998	-	-	-	131.79
Long-Term Debt Repaid	-	-397.16	-320.22	-236.66	-93.69	-34.29
Net Debt Issued (Repaid)	19,586	19,600	-320.22	-236.66	-93.69	97.51
Issuance of Common Stock	334.44	260.9	17,964	-	-	-
Other Financing Activities	-0	-0	-0	-	13,087	-
Financing Cash Flow	19,920	19,861	17,644	-236.66	16,999	97.51
Foreign Exchange Rate Adjustments	796.22	390.05	-65.54	-15.47	397.85	-185.72
Net Cash Flow	958.98	6,279	12,312	-5,407	3,960	-644.51
Free Cash Flow	-10,740	-9,956	-8,376	-10,711	-5,387	-2,849
Free Cash Flow Margin	-273.83%	-217.02%	-123.39%	-148.00%	-97.54%	-64.99%
Free Cash Flow Per Share	-667.42	-604.30	-585.95	-1509.32	-826.72	-437.27
Cash Interest Paid	33.58	34.68	25.7	29.23	9.35	3.2
Cash Income Tax Paid	57.56	50.11	11.81	16.14	-3.84	8.8
Levered Free Cash Flow	3,085	3,490	-3,723	-8,886	-4,602	-
Unlevered Free Cash Flow	3,778	3,929	-3,707	-7,150	-3,537	-
Change in Net Working Capital	-8,963	-9,350	-1,278	1,448	-85.32	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.